Stempeutics ties up with Cipla for its stem cell drug
Stempeutics has inked an out-licensing deal with Cipla, for its stem cell therapy product Stempeucel. It is suggested for treating critical limb ischemia. In a...
Tag : Stempeutics
Stempeutics has got DCGI approval for stem cell based product
Stempeutics Research has got the limited approval from the national drug regulator, DCGI, for its stem cell based product Stempeucel to treat Buerger’s Disease. Cipla,...
